Compare MIRM & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIRM | SA |
|---|---|---|
| Founded | 2018 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.7B |
| IPO Year | 2019 | N/A |
| Metric | MIRM | SA |
|---|---|---|
| Price | $100.65 | $34.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $102.64 | $65.00 |
| AVG Volume (30 Days) | 733.0K | ★ 1.4M |
| Earning Date | 02-26-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $471,794,000.00 | N/A |
| Revenue This Year | $55.91 | N/A |
| Revenue Next Year | $23.97 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 53.66 | N/A |
| 52 Week Low | $36.88 | $9.40 |
| 52 Week High | $105.74 | $37.99 |
| Indicator | MIRM | SA |
|---|---|---|
| Relative Strength Index (RSI) | 64.68 | 58.80 |
| Support Level | $97.49 | $27.51 |
| Resistance Level | $105.74 | $30.75 |
| Average True Range (ATR) | 3.71 | 2.33 |
| MACD | -0.79 | 0.06 |
| Stochastic Oscillator | 62.01 | 64.65 |
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.